22533

0

DHTL

img img img img
No Data Available

DOCMODE HEALTH TECH LTD Share Price Update

As of the latest trading session, DOCMODE HEALTH TECH LTD is trading at ₹51, up by ₹0.00 or 0.00% from its previous close. The stock has moved between ₹49.00 and ₹51.00 today. Over the past year, the stock has delivered a return of -18.26%. In the last month, it has returned 21.42%.

DOCMODE HEALTH TECH LTD performance

Today’s low Today’s high
₹ 49.00 ₹ 51.00
₹ 51.00
52 week low 52 week high
₹ 36.90 ₹ 125.20
₹ 51.00
Open Price ₹ 49.00
Prev. Close ₹ 51.00
Volume (Shares) 1600.00
Total traded value ₹ .81
Upper Circuit ₹ 53.55
Lower Circuit ₹ 48.45
info

Investment Returns

Over 1 Month 21.42% Over 3 Months 14.34% Over 6 Months -55.65% Over 1 Year -18.26%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

DOCMODE HEALTH TECH LTD fundamentals


  • Market cap (Cr) 16.00
  • P/E Ratio (TTM) -7.89
  • Beta -0.35
  • Book Value / share 26.57
  • Return on equity -21.68%
  • EPS (TTM) 0.00
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 0.00
info icon alternate text
  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) [-]
info icon alternate text

DOCMODE HEALTH TECH LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2025 (Values in Cr)
Revenue 41.77
Operating Expense 44.66
Net Profit -2.03
Net Profit Margin (%) -4.85
Earnings Per Share (EPS) -6.46
EBITDA 0.23
Effective Tax Rate (%) -3.04
Particulars MAR 2024 (Values in Cr)
Revenue 40.01
Operating Expense 39.80
Net Profit 0.19
Net Profit Margin (%) 0.47
Earnings Per Share (EPS) 0.62
EBITDA 2.02
Effective Tax Rate (%) 42.85
Particulars MAR 2023 (Values in Cr)
Revenue 32.88
Operating Expense 30.27
Net Profit 1.95
Net Profit Margin (%) 5.93
Earnings Per Share (EPS) 8.50
EBITDA 3.84
Effective Tax Rate (%) 27.50
Particulars MAR 2025 (Values in Cr)
Book Value / Share 26.56
ROE % -21.69
ROCE % -0.28
Total Debt to Total Equity 0.85
EBITDA Margin 0.60
Particulars MAR 2024 (Values in Cr)
Book Value / Share 33.01
ROE % 2.75
ROCE % 12.25
Total Debt to Total Equity 1.28
EBITDA Margin 5.05
Particulars MAR 2023 (Values in Cr)
Book Value / Share 15.15
ROE % 80.25
ROCE % 40.10
Total Debt to Total Equity 2.74
EBITDA Margin 11.68
Particulars MAR 2022 (Values in Cr)
Book Value / Share 1387.10
ROE % 98.92
ROCE % 45.36
Total Debt to Total Equity 3.17
EBITDA Margin 15.30
Particulars MAR 2021 (Values in Cr)
Book Value / Share 465.20
ROE % 230.08
ROCE % 97.18
Total Debt to Total Equity 2.84
EBITDA Margin 12.25
Particulars MAR 2025 (Values in Cr)
Book Value / Share 26.58
ROE % -21.68
ROCE % -0.33
Total Debt to Total Equity 0.85
EBITDA Margin 0.57
Particulars MAR 2024 (Values in Cr)
Book Value / Share 33.04
ROE % 2.74
ROCE % 12.18
Total Debt to Total Equity 1.27
EBITDA Margin 5.05
Particulars MAR 2023 (Values in Cr)
Book Value / Share 15.17
ROE % 80.08
ROCE % 40.08
Total Debt to Total Equity 2.74
EBITDA Margin 11.68
Particulars MAR 2022 (Values in Cr)
Book Value / Share 1390.50
ROE % 98.92
ROCE % 45.36
Total Debt to Total Equity 3.17
EBITDA Margin 15.38
Particulars MAR 2021 (Values in Cr)
Book Value / Share 466.50
ROE % 229.17
ROCE % 97.08
Total Debt to Total Equity 2.84
EBITDA Margin 12.25
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.83
Total Assets 39.31
Total Liabilities 39.31
Total Equity 8.34
Share Outstanding 0
Price to Book Ratio 1.86
Return on Assets (%) -5.15
Return on Capital (%) -13.36
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 3.10
Total Assets 30.14
Total Liabilities 30.14
Total Equity 10.37
Share Outstanding 0
Price to Book Ratio 6.47
Return on Assets (%) 0.62
Return on Capital (%) 0.96
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.38
Total Assets 17.00
Total Liabilities 17.00
Total Equity 3.47
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 11.45
Return on Capital (%) 16.3
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.13
Total Assets 10.08
Total Liabilities 10.08
Total Equity 1.38
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 9.14
Return on Capital (%) 14.81
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.30
Total Assets 5.67
Total Liabilities 5.67
Total Equity 0.46
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 9.75
Return on Capital (%) 36.37
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.78
Total Assets 39.31
Total Liabilities 39.31
Total Equity 8.35
Share Outstanding 0
Price to Book Ratio 1.86
Return on Assets (%) -5.16
Return on Capital (%) -13.38
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 3.08
Total Assets 30.17
Total Liabilities 30.17
Total Equity 10.38
Share Outstanding 0
Price to Book Ratio 6.47
Return on Assets (%) 0.64
Return on Capital (%) 0.99
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.38
Total Assets 17.01
Total Liabilities 17.01
Total Equity 3.47
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 11.45
Return on Capital (%) 16.3
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.13
Total Assets 10.08
Total Liabilities 10.08
Total Equity 1.39
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 9.16
Return on Capital (%) 14.83
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.30
Total Assets 5.67
Total Liabilities 5.67
Total Equity 0.46
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 9.75
Return on Capital (%) 36.33
Particulars MAR 2025 (Values in Cr)
Net Income -1.96
Cash from Operations 6.80
Cash from Investing -3.67
Cash from Financing -4.27
Net change in Cash -1.26
Free Cash Flow 10.45
Particulars MAR 2024 (Values in Cr)
Net Income 0.33
Cash from Operations 4.50
Cash from Investing -7.54
Cash from Financing 5.75
Net change in Cash 2.71
Free Cash Flow 11.92
Particulars MAR 2023 (Values in Cr)
Net Income 2.69
Cash from Operations -0.84
Cash from Investing -1.57
Cash from Financing 2.65
Net change in Cash 0.24
Free Cash Flow 0.75
Particulars MAR 2022 (Values in Cr)
Net Income 1.50
Cash from Operations -1.94
Cash from Investing -1.52
Cash from Financing 3.40
Net change in Cash -0.16
Free Cash Flow -1.58
Particulars MAR 2021 (Values in Cr)
Net Income 0.64
Cash from Operations -0.49
Cash from Investing -0.13
Cash from Financing 0.84
Net change in Cash 0.21
Free Cash Flow -0.46
Particulars MAR 2025 (Values in Cr)
Net Income -1.97
Cash from Operations 6.77
Cash from Investing -3.67
Cash from Financing -4.26
Net change in Cash -1.29
Free Cash Flow 10.41
Particulars MAR 2024 (Values in Cr)
Net Income 0.34
Cash from Operations 4.48
Cash from Investing -7.54
Cash from Financing 5.76
Net change in Cash 2.70
Free Cash Flow 11.90
Particulars MAR 2023 (Values in Cr)
Net Income 2.69
Cash from Operations -0.84
Cash from Investing -1.57
Cash from Financing 2.65
Net change in Cash 0.24
Free Cash Flow 0.75
Particulars MAR 2022 (Values in Cr)
Net Income 1.50
Cash from Operations -1.94
Cash from Investing -1.52
Cash from Financing 3.40
Net change in Cash -0.16
Free Cash Flow -1.58
Particulars MAR 2021 (Values in Cr)
Net Income 0.64
Cash from Operations -0.49
Cash from Investing -0.13
Cash from Financing 0.84
Net change in Cash 0.21
Free Cash Flow -0.46
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
IRONWOOD EDUCATION LIMITED 43.02 24.03 2.79 72.19 32.27 57.00
LCC INFOTECH LTD. 5.07 0.00 58.20 64.18 3.70 6.76
VIRTUAL GLOBAL EDUCATION LTD. 0.58 0.00 0.41 32.84 0.42 0.69
CL EDUCATE LIMITED 46.43 0.00 0.99 251.76 35.64 120.73
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
IRONWOOD EDUCATION LIMITED 43.02 0.00 2.15 72.19 32.27 57.00
WINSOME BREWERIES LTD. 22.56 0.00 1.80 62.42 17.50 37.10
DSJ KEEP LEARNING LIMITED 2.15 0.00 4.47 33.48 1.48 4.06
ACE EDUTREND LTD. 4.70 0.00 0.53 4.31 3.33 4.70

DOCMODE HEALTH TECH LTD shareholding pattern

Holding
70.5%
29.49%
37.37%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

DOCMODE HEALTH TECH LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
51.00 0.00 redarrow
red-green-graph indicator
6 Bearish
10 Bullish
  • 5 Days 47.10
  • 26 Days 48.60
  • 10 Days 45.40
  • 50 Days 56.30
  • 12 Days 45.30
  • 100 Days 64.30
  • 20 Days 46.80
  • 200 Days 77.10
50.33 PIVOT
First Support 49.67 First Resistance 51.67 Second Support 48.33 Second Resistance 52.33 Third Support 47.67 Third Resistance 53.67
RSI 54.13 ADX 57.25 MACD -3.33 Williams % R 0.00 Commodity Channel Index (CCI) 177.26
Date 2026-05-20 Week 1600.00 Same Day 1600.00 Month 1440.00
1 Year -0.36 3 Year -0.02
Over 1 Month
21.42% down
Over 1 Year
-18.26% down
Over 3 Months
14.34% down
Over 3 Years
-34.41% down
Over 6 Months
-55.65% down
Over 5 Years
0.00% down

DOCMODE HEALTH TECH LTD Corporate Actions

Top Gainers

Top Losers

DOCMODE HEALTH TECH LTD Share Price

Docmode Health Technologies Limited was incorporated on July 17, 2017 as a private limited Company with the Deputy Registrar of Companies Mumbai. Thereafter, the Company was converted into a Public Limited Company and through effect in conversion of legal status dated January 2, 2023.

DocMode is a pioneering healthcare technology company that is transforming the landscape of medical education, research, and practice. With a vision to 'Transform Learning & Practice' in the medical fraternity, the Company has established itself as a leading provider of integrated learning solutions, cutting-edge practice tools, and comprehensive research platforms. The Company is in the business of offering integrated learning solutions through online and offline learning model to Health care Professionals and learners across the world, spanning the education value chain.

The Promoters have experience in healthcare advertising, health IT, healthcare communications, healthcare event management and broadcasting who so far have developed 'iNutrimon' application for clinical nutrition delivery management for ICU patients, entire IPD as well as OPD patient requirements of a hospital or healthcare service provider.

The Company mainly focus on providing learning solutions through online model. The online learning model comprises notes, recorded videos, live conferences, workshops etc. In addition to the learning solutions, it provide a platform for inter-professional cross industrial learning via panel discussion and courses as well as take advantage of their performance assessment tools to better their clinical acumen in their daily medical practice. The offline learning model comprises of conferences and workshops. Online courses content is reviewed and presented by Content Development Team (CDT) or by Medical Institution and Medical Associations (medical professional bodies) and subject matter experts/key opinion leaders who are focused to effectively transfer knowledge, as well as communicate and network with each other through their learning and professional networking platform.

The Company has network of doctors in varied specialists such as general practitioners to consultants and to super specialists. Apart from this, the Company offer services to Health Care Professionals like DocMode LERN, including doctors, physicians, surgeon and allied healthcare professionals such as dieticians, physiotherapist, nurses, technicans and paramedics.

In Sep' 21, the Company had introduced Gapsule platform to bridge knowledge gap and ensure uninterrupted flow of information between pharmaceutical industry, medical practitioners and healthcare providers to plug gaps in knowledge-sharing for better healthcare outcomes. As on February 28, 2023 it has installed application around 20 hospitals and 50+ standalone healthcare providers such as dietician.

As of February 2023, iNutrimon has been installed in around 20 hospitals and 50+ standalone healthcare providers such as dieticians.

Company made a fresh issue of 8,49,600 Equity Shares through IPO of face value of Rs 10/- each by raising funds aggregating to Rs 6.71 Cr in January, 2024.

The Company's flagship products, such as iNutrimon (clinical nutrition management) and AIDE (AI-powered clinical decision support), have gained widespread recognition and adoption. Additionally, the successful launch of the SURE platform has established DocMode as a trusted partner for evidence-based research and market intelligence.

The Company transferred 5% stake held in CCME World Services Pvt. Ltd. to Mr. Amarjeet Thakur w.e.f 1st April, 2024, thereby CCME ceased to be a wholly owned subsidiary of the Company and became a subsidiary of the Company in 2024.

Company has altered its Main Object and have added objects related to healthcare, chemicals, research etc. on September 30, 2024.

The domestic and international expansion into Contract Research Organization (CRO) and CRAMS services have marked a defining step for the Company in FY 2025. As of March 31, 2025, Company has expanded its certificate program courses portfolio, having associated with leading medical associations and universities across the globe.

Parent organization Indian Private
NSE symbol DHTL
Founded 2017
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Docmode Health Technologies Ltd?

Answer Field

Docmode Health Technologies Ltd share price is for NSE ₹ 51.00 & for BSE ₹ 0.00 as on May 20 2026 02:38 PM.

What is the Market Cap of Docmode Health Technologies Ltd Share?

Answer Field

The market cap of Docmode Health Technologies Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on May 20 2026 02:38 PM.

What is the 52 Week High and Low of Docmode Health Technologies Ltd?

Answer Field

The 52 Week High and Low of Docmode Health Technologies Ltd for NSE is ₹ 125.20 and ₹ 36.90 and for BSE is ₹ 0.00 and ₹ 0.00.

What is 1 year return for Docmode Health Technologies Ltd?

Answer Field

The 1 year returns on the stock has been -18.26%.

What is the P/E Ratio of Docmode Health Technologies Ltd Share?

Answer Field

As on May 20 2026 02:38 PM the price-to-earnings (PE) ratio for Docmode Health Technologies Ltd share is -7.89.

What is the PB ratio of Docmode Health Technologies Ltd Share?

Answer Field

As on May 20 2026 02:38 PM, the price-to-book (PB) ratio for Docmode Health Technologies Ltd share is 26.57.

How to Buy Docmode Health Technologies Ltd Share?

Answer Field

You can trade in Docmode Health Technologies Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Docmode Health Technologies Ltd Share on Bajaj Broking App?

Answer Field

To buy Docmode Health Technologies Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Docmode Health Technologies Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|